"
Template:SupbiotechparisFr
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 59: | Line 59: | ||
<div id="menu"> | <div id="menu"> | ||
<div style="margin-bottom: 40px; margin-top: 320px; background: transparent;"> | <div style="margin-bottom: 40px; margin-top: 320px; background: transparent;"> | ||
| - | <span style="color: | + | <span style="color: white;"> '''Projet''' </span><br> |
| - | '''Introduction''' | + | |
| + | <span style="color: gold;">'''Introduction'''</span><br> | ||
| + | <div style="color: black;"> | ||
*[[Team:SupBiotech-Paris/Thérapies actuelles|Thérapies actuelles]] | *[[Team:SupBiotech-Paris/Thérapies actuelles|Thérapies actuelles]] | ||
*[[Team:SupBiotech-Paris/Thérapies géniques|Thérapies géniques]] | *[[Team:SupBiotech-Paris/Thérapies géniques|Thérapies géniques]] | ||
| - | '''1er Constat''' | + | |
| + | <span style="color: gold;">'''1er Constat'''</span><br> | ||
| + | <div style="color: black;"> | ||
*[[Team:SupBiotech-Paris/Introduction1Fr|Introduction]] | *[[Team:SupBiotech-Paris/Introduction1Fr|Introduction]] | ||
*[[Team:SupBiotech-Paris/Concept1Fr|Concept]] | *[[Team:SupBiotech-Paris/Concept1Fr|Concept]] | ||
*[[Team:SupBiotech-Paris/Conclusion1Fr|Conclusion]] | *[[Team:SupBiotech-Paris/Conclusion1Fr|Conclusion]] | ||
| - | '''2nd Constat''' | + | |
| + | <span style="color: gold;">'''2nd Constat'''</span><br> | ||
| + | <div style="color: black;"> | ||
*[[Team:SupBiotech-Paris/Introduction2Fr|Introduction]] | *[[Team:SupBiotech-Paris/Introduction2Fr|Introduction]] | ||
*[[Team:SupBiotech-Paris/Concept2Fr|Concept]] | *[[Team:SupBiotech-Paris/Concept2Fr|Concept]] | ||
*[[Team:SupBiotech-Paris/Conclusion2Fr|Conclusion]] | *[[Team:SupBiotech-Paris/Conclusion2Fr|Conclusion]] | ||
| - | '''Mise en application''' | + | |
| + | <span style="color: gold;">'''Mise en application'''</span><br> | ||
| + | <div style="color: black;"> | ||
*[[Team:SupBiotech-Paris/Ciblage Tissulaire|Ciblage Tissulaire]] | *[[Team:SupBiotech-Paris/Ciblage Tissulaire|Ciblage Tissulaire]] | ||
*[[Team:SupBiotech-Paris/Ciblage Cellulaire|Ciblage Cellulaire]] | *[[Team:SupBiotech-Paris/Ciblage Cellulaire|Ciblage Cellulaire]] | ||
*[[Team:SupBiotech-Paris/ModificationFr|Modification protéique]] | *[[Team:SupBiotech-Paris/ModificationFr|Modification protéique]] | ||
*[[Team:SupBiotech-Paris/Conclusion3Fr|Conclusion]] | *[[Team:SupBiotech-Paris/Conclusion3Fr|Conclusion]] | ||
| + | </div> | ||
Revision as of 17:09, 29 August 2009
Projet
Introduction
1er Constat
2nd Constat
Mise en application
Ressources
Ethique & sûreté
|
|
